WO2019012481A2 - Split g-quadruplexes for capture and detection of nucleic acids - Google Patents
Split g-quadruplexes for capture and detection of nucleic acids Download PDFInfo
- Publication number
- WO2019012481A2 WO2019012481A2 PCT/IB2018/055166 IB2018055166W WO2019012481A2 WO 2019012481 A2 WO2019012481 A2 WO 2019012481A2 IB 2018055166 W IB2018055166 W IB 2018055166W WO 2019012481 A2 WO2019012481 A2 WO 2019012481A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- capture
- split
- quadruplex
- nucleic acid
- tag
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 250
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 248
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 248
- 238000001514 detection method Methods 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 claims abstract description 74
- 108091081406 G-quadruplex Proteins 0.000 claims description 198
- 230000027455 binding Effects 0.000 claims description 155
- 239000007787 solid Substances 0.000 claims description 62
- 125000003729 nucleotide group Chemical group 0.000 claims description 18
- 238000001668 nucleic acid synthesis Methods 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 7
- 238000004132 cross linking Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 230000008685 targeting Effects 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 description 26
- 230000003197 catalytic effect Effects 0.000 description 15
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 14
- 238000011144 upstream manufacturing Methods 0.000 description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 239000002773 nucleotide Substances 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 102000003992 Peroxidases Human genes 0.000 description 8
- 235000020958 biotin Nutrition 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 229940025294 hemin Drugs 0.000 description 7
- 108040007629 peroxidase activity proteins Proteins 0.000 description 7
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000012148 binding buffer Substances 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 6
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 6
- 230000000977 initiatory effect Effects 0.000 description 6
- 239000003607 modifier Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000001960 triggered effect Effects 0.000 description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 5
- 230000026731 phosphorylation Effects 0.000 description 5
- 238000006366 phosphorylation reaction Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 125000006850 spacer group Chemical group 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000009146 cooperative binding Effects 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 4
- 239000004005 microsphere Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 3
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 3
- 101710096438 DNA-binding protein Proteins 0.000 description 3
- 101100523604 Mus musculus Rassf5 gene Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 108091033399 Telomestatin Proteins 0.000 description 3
- 238000003916 acid precipitation Methods 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 3
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 150000008300 phosphoramidites Chemical class 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108091035539 telomere Proteins 0.000 description 3
- 102000055501 telomere Human genes 0.000 description 3
- 210000003411 telomere Anatomy 0.000 description 3
- YVSQVYZBDXIXCC-INIZCTEOSA-N telomestatin Chemical compound N=1C2=COC=1C(N=1)=COC=1C(N=1)=COC=1C(N=1)=COC=1C(N=1)=COC=1C(=C(O1)C)N=C1C(=C(O1)C)N=C1[C@@]1([H])N=C2SC1 YVSQVYZBDXIXCC-INIZCTEOSA-N 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 3
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102100035254 Sodium- and chloride-dependent GABA transporter 3 Human genes 0.000 description 2
- 101710104417 Sodium- and chloride-dependent GABA transporter 3 Proteins 0.000 description 2
- -1 TMPyP4 Chemical compound 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 150000001615 biotins Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 239000002608 ionic liquid Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000001821 nucleic acid purification Methods 0.000 description 2
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- JFZKOODUSFUFIZ-UHFFFAOYSA-N trifluoro phosphate Chemical compound FOP(=O)(OF)OF JFZKOODUSFUFIZ-UHFFFAOYSA-N 0.000 description 2
- KHNDABJZSPPYLE-FUGFVFQCSA-N (2,5-dioxopyrrolidin-1-yl) 6-[[2-[[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2h-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]acetyl]amino]hexanoate Chemical compound O([C@@H]1C[C@H]2CC[C@H]3[C@@]4(O)CC[C@@H]([C@]4([C@@H](C[C@@H]3[C@@]2(C)CC1)O)C)C=1COC(=O)C=1)CC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O KHNDABJZSPPYLE-FUGFVFQCSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 101710185494 Zinc finger protein Proteins 0.000 description 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229950004398 broxuridine Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000012650 click reaction Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000016914 ras Proteins Human genes 0.000 description 1
- 108010014186 ras Proteins Proteins 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- QOFZZTBWWJNFCA-UHFFFAOYSA-N texas red-X Chemical compound [O-]S(=O)(=O)C1=CC(S(=O)(=O)NCCCCCC(=O)O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 QOFZZTBWWJNFCA-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
Definitions
- the invention relates to methods of associating functional tags to target nucleic acids, and uses thereof, including the detection of target nucleic acids, and the capture of target nucleic acids.
- G-quadruplexes are structures formed in nucleic acids by sequences that are rich in guanine.
- Four guanine bases can associate through Hoogsteen hydrogen bonding to form a square planar structure called a guanine tetrad, and two or more guanine tetrads can stack on one another to form a G-quadruplex .
- the quadruplex structure is further stabilized by the presence of a cation, which sits in a central channel between each pair of tetrads. They can be formed of DNA or RNA (or other nucleic acids); and they typically form from one strand
- G-quadruplexes with 4 G-rich sequences aligned in the same 5'-to-3' direction are termed parallel;
- G-quadruplexes with 2 G-rich sequences aligned 5'-to-3' and 2 G-rich sequences aligned 3'-to-5' direction are termed anti-parallel; and
- G quadruplexes with either 3 G-rich sequences aligned 5'-to-3' and 1 G- rich sequence aligned 3'-to-5', or 1 G-rich sequence aligned 5'-to-3' and 3 G-rich sequences aligned 3'-to-5', are termed mixed or hybrids .
- G-quadruplexes in a parallel topology will have loops in a propeller configuration (positioned to the side of the quadruplex)
- quadruplexes in an anti-parallel topology will have loops in a lateral configuration
- G-quadruplex sequence is present in the genomes of a variety of organisms. In humans, genome-wide surveys have identified >376,000 Putative Quadruplex Sequences, although not all of these probably form in vivo. Some sequences are found in human telomeres with the DNA repeat d(GGTTAG) n . The formation of quadruplexes in telomeres has been shown to decrease the activity of the enzyme telomerase, which is responsible for maintaining the length of telomeres, and is involved in around 85% of all cancers. Other sequences are found in promoter regions of genes, including the proto-oncogenes c-myc, k- ras, c-kit, Bcl-2, and VEGF.
- G- quadruplexes include the DNA binding protein RAPl, the crowding agent polyethylene glycol, and the ionic liquid guanidinium tris (pentafluoroethyl ) trifluorophosphate
- G-IL G-quadruplex-specific antibody 1H6
- a subset of these molecules also stabilizes formation of G-quadruplexes (ex. Gua-IL, TMPyP4, and telomestatin) .
- the G-quadruplex Ligands Database http://www.g41db.org) lists hundreds of molecules that influence or bind G-quadruplexes.
- the G-quarduplex-hemin complex is capable of oxidizing a variety of substrates, including colorimetric and chromogenic substrates (ex. DAB, ABTS) - and chemiluminescent substrates (ex. luminol) - used in peroxidase assays.
- the G-quadruplex- hemin complex is approximately two orders of magnitude more reactive than hemin alone in catalyzing peroxidase reactions .
- G-quadruplexes are considered to be DNA enzymes. Studies have shown that G-quaduplex-hemin complexes are less active than horseradish peroxidase
- HRP HRP but more active than the enzyme catalase.
- the G-quadruplex-hemin complex displays a broader range of substrate specificity than HRP, and a higher rate of self-inactivation than HRP - likely because of a more exposed active site.
- Some studies have shown G-quadruplex activity dependent on ions, buffers, pH, and surfactants - as well as activity enhancement agents such as adenosine triphosphate and spermidine.
- Other studies have shown G-quadruplex activity dependent on loop size, flanking sequence, and topology.
- G- quadruplex-hemin complexes have many advantages in comparison to HRP; however, weaker peroxidase activity and higher inactivation rate have hindered G-quadruplex use as HRP replacements.
- split G-quadruplexes are engineered G- quadruplexes that are used to detect nucleic acids via their inherent catalytic activity. These molecules were first designed by dividing the G-quadruplex sequence into an upstream sequence and a downstream sequence, and attaching target-binding arms to the upstream and downstream sequences.
- split G-quadruplexes comprise two oligonucleotide strands - each with a partial G-quadruplex sequence and a target-binding arm.
- the target-binding arms are single stranded, and designed to bind single stranded target nucleic acid, for example, designed with sequence complementary to the target nucleic acid, and thus capable of binding said nucleic acid. Accordingly, in the presence of the target, the split G-quadruplex binds and its G-quadruplex assembles and becomes competent to catalyze its peroxidase reaction .
- split G-quadruplexes with peroxidase activity to detect nucleic acids is interesting, especially with molecules demonstrating high binding specificity (using short target binding arms) .
- studies have observed low target sensitivity (ex. ⁇ - to-lmM using colorimetric substrates) in comparison to HRP assays (ex. 0. lpM-to-100pM) .
- the low target sensitivity probably reflects the aforementioned limitations of (i) weaker peroxidase activity and (ii) higher inactivation rate in comparison to HRP.
- these limitations have similarly hindered use of split G-quadruplexes as nucleic acid detection agents .
- the present invention describes methods and reagents for associating tags to nucleic acids, the method comprising associating a tag to a split G- quadruplex, and binding a split G-quadruplex to a nucleic acid.
- the tag is a capture tag, which can be used to capture a split G-quadruplex, and accordingly, capture a nucleic acid bound by the split G- quadruplex.
- the tag is a detection tag, which can be used to detect a split G-quadruplex, and accordingly, detect a nucleic acid bound by the split G- quadruplex .
- Tags are nucleic acid modifications that impart characteristic features to the nucleic acid, such as the ability to be captured, detected, targeted, or crosslinked. Tags are known in the art, commonly sold by oligonucleotide manufacturers, and can be bound or incorporated into nucleic acids, such as attachment chemistries, fluorophores , detectable enzymes, detectable particles, and nucleotide analogs.
- the disclosure provides a kit for capturing or detecting nucleic acids comprising a split G-quadruplex and an associated tag used to capture or detect said split G-quadruplex.
- the disclosure provides an apparatus for capturing or detecting nucleic acids comprising a split G-quadruplex and an associated tag used to capture or detect said split G-quadruplex.
- Figure 1 is an illustration of six embodiments of the disclosed invention for the capture or detection of target nucleic acids (dashed line) utilizing split G- quadruplexes associated with capture tags (C) or detection tags (D) .
- an antibody (Ab) a split G-quadruplex (SQ) , and a split-G-quadruplexes with capture arms (SQB) are illustrated.
- Some embodiments feature a capture nucleic acid (solid line) .
- the present invention describes a surprisingly stable interaction between split G-quadruplexes and target nucleic acids.
- the high binding affinity of split G-quadruplexes does not require peroxidase activity - and likely reflects formation of the G-quadruplex upon target binding, which physically links the two target binding arms of the split G-quadruplex.
- the combination of high binding affinity and high binding specificity are features shared with antibodies, which are used to associate (or bridge) tags to antigens. Accordingly, the present invention discloses the use of split G-quadruplexes to associate tags to nucleic acids, for example, in methodologies to capture nucleic acids, and methodologies to detect nucleic acids.
- the present invention also discloses the use of split G-quadruplexes (in place of antibodies) in several antibody methodologies adapted for nucleic acids, including purification, precipitation, targeting, crosslinking, and modification of nucleic acids - as well as kits and apparatuses based on said methodologies.
- split G-quadruplexes are engineered G- quadruplexes designed to bind target sequences in target nucleic acids, and upon binding, assemble into G- quadruplexes .
- These molecules can comprise two, three, or four strands of nucleic acid, with (i) each strand containing a partial sequence of a G-quadruplex, and (ii) two or more strands with single-stranded target-binding arms, each capable of binding part of a single-stranded target sequence of the target nucleic acid.
- target-binding arms are designed with sequence capable of binding the target sequence, for example, by hybridization.
- target- binding arms are designed with sequence complementary to the target sequence, and thus are capable of binding the target sequence by hybridization.
- the sum of the partial sequences of the split G-quadruplex is a G-quadruplex
- the sum of the target-binding arm sequences is a sequence complementary to the target sequence.
- a split G- quadruplex of two strands can have a first strand with either (i) the 5' -end of the target binding arm (with upstream complementary target sequence) attached to the 3' -end of the upstream G-quadruplex sequence, or preferentially (ii) the 3' -end of the target binding arm
- a split G-quadruplex strand is attached to two or more target binding arms.
- the target-binding arms are attached to the partial G- quadruplex sequences via a linker or spacer - such as Phosphoramidite C3, Hexanediol, and 1 ' , 2 ' -Dideoxyribose, and preferentially via the spacers Triethylene Glycol or Hexa-Ethyleneglycol .
- a linker or spacer - such as Phosphoramidite C3, Hexanediol, and 1 ' , 2 ' -Dideoxyribose
- split G-quadruplex strands can be designed with different combinations of partial G-quadruplex sequences.
- a split G-quadruplex of two strands can have a first strand with 3 G-rich sequences and 2 loops of a G-quadruplex, and a second strand with 1 G-rich sequence of a G-quadruplex.
- the first strand and second strands each comprise 2 G-rich sequences and 1 loop of a G-quadruplex.
- the first strand comprises the G-quadruplex sequence G3 + Ni_ 7+ G 3+ Ni_ 7+ G3
- the second strand comprises the G-quadruplex sequence G3, wherein N is any base including guanine.
- the first and second strand sequences each comprise the G- quadruplex sequence G 3+ Ni_ 7+ G 3 , wherein N is any base including guanine.
- the first strand comprises the G-quadruplex sequence GGGTAGGG
- the second strand comprises the G- quadruplex sequence GGGTTGGG.
- split G-quadruplexes of three and fours strands can be designed by dividing (splitting) the above G-rich sequences, such as one 2 G- rich and two 1 G-rich strands for a three strand G- quadruplex, and four 1 G-rich strands for a four strand quadruplex .
- a target sequence can be a single continuous sequence in the target nucleic acid. Accordingly, in one embodiment, the target binding arms of the split G- quadruplex are designed to bind two flanking regions
- a target sequence can also be two or more physically separate sequences (ex. parts, separated by non-target sequence) in the target nucleic acid.
- the target-binding arms of the split G- quadruplex are designed to bind two or more physically separate sequences of the target sequence.
- one or more target binding arms are made short in length, so in the chosen conditions and temperature for binding, the split G-quadruplex hybridizes to perfect target sequences and not alternative sequences, including sequences with nucleotide substitutions, such as single nucleotide polymorphisms (SNPs) .
- the short length can be selected by (1) choosing a temperature for operation of the split G-quadruplex (ex.
- split G-quadruplexes are used with molecules that influence the formation of G- quadruplexes , or bind to G-quadruplexes.
- split G-quadruplexes are used with molecules that induce the formation of G-quadruplexes, such as cations (ex. Na + , K + , NH 4 + ) , the DNA binding protein RAPl, the crowding agent polyethylene glycol, and the ionic liquid guanidinium tris (pentafluoroethyl ) trifluorophosphate (Gua-IL) .
- split G-quadruplexes are used with molecules that stabilize the formation of G- quadruplexes , such as Gua-IL, TMPyP4, and telomestatin .
- split G-quadruplexes are used with molecules that promote the catalytic activity of G-quadruplexes, such as ATP.
- G-quadruplexes designed with short loops favor parallel topologies
- G-quadruplexes with long loops favor anti-parallel topologies
- G-quadruplexes treated with K + favor parallel topologies
- G-quadruplexes treated with Na + favor anti-parallel topologies.
- split G-quadruplexes can be similarly designed or treated to favor parallel topologies or favor anti- parallel topologies.
- Tags are nucleic acid modifications that can be associated - ex. bound or incorporated - to nucleic acids, and similarly, can be associated - ex. bound or incorporated - to split G-quadruplexes.
- Tags are functional, and their association to a nucleic acid imparts their function to the nucleic acid.
- a tag that can be detected (ex. a detection tag), bound or incorporated to a nucleic acid, permits said nucleic acid to be detected.
- a tag that can be captured (ex. a capture tag), bound or incorporated to a nucleic acid, permits said nucleic acid to be captured.
- a tag that can be targeted ex.
- a target tag bound or incorporated to a nucleic acid
- a tag that can be crosslinked (ex. a crosslinked tag), bound or incorporated to a nucleic acid, permits said nucleic acid to be crosslinked.
- Tags are usually associated to nucleic acids by binding or incorporation to the nucleic acid (ex. during nucleic acid synthesis) .
- Tags and nucleic acid modifications are known in the art, and many are available from oligonucleotide manufacturers.
- detection tags include fluorophores , quenchers, phosphoylation, detectable enzymes (horseradish peroxidase), dyes, reactants (ex. acrydite) , detectable particles, and nucleotide analogs (ex.
- capture tags include attachment chemistries, binding chemistries, phosphorylation, antibody antigens, antibodies, nucleotide analogs (ex. that are antibody antigens), and nucleotide sequences (ex. that hybridize to other nucleic acids); and include adenylation, alkyne modifiers (ex.
- tags include cholesterol and phosphorylation.
- crosslink tags include 5-bromo-deoxyuridine.
- Other tags such as nucleotide analogs (which include modified nucleotides, ex. nucleotides with modified nucleobases ) , have members with functions similar to the aforementioned tags, such as 2-aminopurine (detection) and 5-bromo-2 ' -deoxyuridine (BrdU) ( crosslinking) .
- Detection tags are nucleic acid modifications that can be detected, for example, by senses (ex. visually), or by use of assays or equipment (ex. measuring the presence, amount, or functional activity of the detection tag) .
- Commonly used detection tags are fluorophores and quenchers, which can be detected by fluorometer or microscope.
- Other detection tags that can be used include phosphorylation and nucleotide analogs (ex. radiolabeled and detected by scintillation counter or autoradioagraphy (ex. film)), detectable enzymes (ex. horseradish peroxidase), detectable particles (ex. colloidal gold and colored latex), and BrdU (ex. crosslinking the labeled nucleic acid (ex. the split G- quadruplex) with the target nucleic acid, and then measuring the presence of the two crosslinked nucleic acids by electrophoresis or chromatography) .
- Capture tags are nucleic acid modifications that bind, or are capable of binding, to specific molecules - herein called capture targets. Some capture tags rely on high-affinity non-covalent bonds for capture target binding, such as biotin (binding to avidin) and digoxigenin and 2 , 4-dinitrophenol (binding to anti-DIG and anti-DNP antibodies, respectively) . Other capture tags rely on covalent bonds for capture target binding, which often require chemical treatment to activate reactive groups on the capture tag (or capture target) , such as amino modifiers, alkyne modifiers, and thiol modifiers. Examples of capture targets include nucleic acids (including the herein capture nucleic acids), molecules than can be detected (ex. dyes and enzymes), molecules capable of binding other molecules (ex. antigens and antibodies), and solid surfaces.
- Target tags such as cholesterol and phosphorylation can be used to facilitate nucleic acid uptake into cells.
- Target tags can be similarly incorporated into a split G-quadruplex, for example, to facilitate its uptake into cells, and to facilitate the uptake of target nucleic acids bound by the split G- quadruplex.
- split G-quadruplexes can also be associated with DNA regulatory molecules - ex. enzymes, nucleases, transcription factors, enzyme inhibitors, enzymes subtrates, enzymes catalysts, etc. - in order to target said molecules to specific target nucleic acids within cells, for example, for use in gene regulation, protein expression via RNA regulation, or anti-viral or anti-bacterial therapy.
- Crosslink tags such as BrdU are used to crosslink target nucleic acids to other nucleic acids or proteins. Crosslink tags can similarly be incorporated into a split G-quadruplex in order to crosslink it to other nucleic acids, or to other proteins, which then can be associated to a target nucleic acid by binding said split G-quadruplex to the target nucleic acid.
- Split G-quadruplexes can contain one or more tags - bound or incorporated in one, two, three, or four of its strands.
- the tags can be placed on the 5' -end, 3'- end, or the middle of a strand, and different tags can be placed on one strand or different strands of the split G- quadruplex.
- tags are placed distant from the partial G-quadruplex, for example, one strand can have a tag bound or incorporated to the 5' -end of a target-binding arm, and the 3' -end of the target-binding arm attached to the 5' -end of the partial G-quadruplex sequence.
- Such a configuration may be desired if the capture tag - or capture target (ex.
- tags are placed proximal to the partial G- quadruplex, for example, one strand can have the 3' -end of the target-binding arm attached to the 5' -end of the partial G-quadruplex sequence, and the 3' -end of the partial G-quadruplex sequence bound or incorporated with the tag.
- capture tags ex. biotins
- target molecule ex.
- Additional target-binding arms - capable of binding other nucleic acid sequences - can be added to split G-quadruplexes to capture other target nucleic acids. These additional arms function as sequence- dependent capture tags, capable of binding nucleic acids as their capture targets, and can be designed similarly to, or different from, the aforementioned target-binding arms. Accordingly, herein, different nomenclature is utilized, where these additional target-binding arms are called capture arms, which bind target sequences called capture sequences, that are present in target nucleic acids called capture nucleic acids.
- capture arms are designed similarly to target-binding arms, wherein each strand of the split G-quadruplex contains a single-stranded capture arm, which is capable of binding part of the single-stranded capture sequence of the capture nucleic acid.
- one or more capture arms are made short in length, so in the chosen conditions and temperature for binding, the split G-quadruplex hybridizes to perfect capture sequences and not alternative sequences, including sequences with nucleotide substitutions, such as SNPs .
- capture arms are designed differently to target-binding arms, wherein one strand of the split G-quadruplex contains a capture arm, which is capable of binding the entire capture sequence of the capture nucleic acid.
- the sum of the capture arm sequences is a sequence complementary to the capture sequence.
- a split G-quadruplex of two strands can have a first strand with the 3' -end of the target binding arm (with upstream complementary target sequence) attached to the 5' -end of the upstream G-quadruplex sequence, and the 3' -end of the upstream G-quadruplex sequence attached to the 5' -end of the capture arm (with downstream complementary capture sequence); and the 3' -end of the capture arm (with upstream complementary capture sequence) attached to the 5' -end of the downstream G- quadruplex sequence, and 3' -end of the downstream G- quadruplex sequence attached to the 5' -end of the target- binding arm (with downstream complementary target sequence) .
- the target-binding arms and the capture arms are attached to the partial G- quadruplex sequences via a linker or spacer - such as Phosphoramidite C3, Hexanediol, and 1 ' , 2 ' -Dideoxyribose, and preferentially via the spacers Triethylene Glycol or Hexa-Ethyleneglycol .
- a linker or spacer - such as Phosphoramidite C3, Hexanediol, and 1 ' , 2 ' -Dideoxyribose
- Capture nucleic acids can be bound or incorporated with functional tags; for example, detection tags, capture tags, target tags, or crosslinked tags. Accordingly, capture nucleic acids can be used to associate functional tags to target nucleic acids; for example (i) a functional tag is associated to a capture nucleic acid, (ii) said capture nucleic acid is bound to the capture arms of a split G-quadruplex, and (iii) the target binding arms of said G-quadruplex is bound to a target nucleic acid. Such methods permit the use of capture nucleic acids with split G-quadruplexes to detect, capture, target, or crosslink target nucleic acids.
- methods are described below for the detection of target nucleic acids using a capture nucleic acid with a detection tag, and split G-quadruplexes .
- methods are described below for the capture of target nucleic acids onto a solid surface using capture nucleic acids with capture tags, and split G- quadruplexes .
- target nucleic acids are detected by (i) associating a detection tag to a split G- quadruplex, (ii) binding said split G-quadruplex to the target nucleic acid, and (iii) detecting the detection tag with a method known in the art.
- detection tags include fluorophores , quenchers, phosphoylation, and nucleotide analogs.
- target nucleic acids are detected by (i) binding a split G-quadruplex to a target nucleic acid,
- the target nucleic acid is bound to a solid surface - either (i) before the target nucleic acid is bound to the split G-quadruplex; or (ii) after the target nucleic acid is bound to the split G-quadruplex, but before detection of the detection tag - permitting washing of said target nucleic acid and removal of unbound detection tags before detection (of bound detection tags) .
- Figure 1 Embodiment 1 An illustration of a target nucleic acid associated to a detection tag using said methods and a solid surface (i.e. preferred embodiment) is shown in Figure 1 Embodiment 1.
- a second approach to detect target nucleic acids uses capture tags to bind capture targets that can be detected, or capture targets that can bind detectable molecules.
- detectable capture targets include detection tags and immunoassay labels, and detectable enzymes, fluorophores , detectable particles, and radiolabeled molecules.
- detectable enzymes include enzymes that catalyze chromogenic or chemiluminescent reactions, such as alkaline phosphatase (AP) , horseradish peroxidase
- HRP horseradish peroxidase
- b-gal beta-galactosidase
- LOC luciferase
- DNA enzymes such as Catalytic G-Quadruplexes .
- detectable fluorophores include fluorescein isothiocyanate (FITC) and tetramethylrhodamine (TRITC) .
- detectable particles include colloidal gold, colored or fluorescent latex, and paramagnetic latex particles.
- detectable radiolabeled molecules include antibodies and antigens labeled with 125-1 or 3-H.
- target nucleic acids are detected using capture tags and capture targets by (i) associating a capture tag to a split G-quadruplex, (ii) binding said split G-quadruplex to a target nucleic acid,
- target nucleic acids are detected using capture tags and capture targets by (i) associating a capture tag to a split G-quadruplex, (ii) binding a detectable capture target to said capture tag, (iii) binding said split G- quadruplex to a target nucleic acid, and (iv) detecting the detectable capture target with a method known in the art.
- target nucleic acids are detected using capture tags and capture targets by (i) binding a split G-quadruplex to a target nucleic acid, (ii) associating a capture tag to said split G- quadruplex, (iii) binding a detectable capture target to said capture tag, and (iv) detecting the capture target with a method known in the art.
- capture targets that can be detected can be utilized, or capture targets capable of binding detectable molecules can be utilized.
- Methods of binding capture tags to capture targets, and binding capture targets to detectable molecules are known in the art.
- the target nucleic acid is bound to a solid surface - either (i) before the target nucleic acid is bound to the split G-quadruplex; or (ii) after the target nucleic acid is bound to the split G-quadruplex, but before detection - permitting washing of said target nucleic acid and removal of unbound detectable capture targets or molecules before detection.
- An illustration of a target nucleic acid associated to a detectable capture target using said methods and a detectable molecule and a solid surface (i.e. preferred embodiment) - is shown in Figure 1 Embodiment 2.
- detection methods can be improved if combined with secondary methods that (i) amplify the signal of detection tags, detectable capture targets, or detectable molecules; or (ii) capture additional detection tags, detectable capture targets, or detectable molecules.
- methods to amplify signals include methods to improve the stability of detection tags, detectable capture targets, or detectable molecules (ex. addition of dextran to HRP) ; and methods to improve the catalytic activity of detection tags, detectable capture targets, or detectable molecules (ex. addition of PEG to prevent HRP inactivation) .
- methods to capture (or cascade) additional detection tags, detectable capture targets, or detectable molecules include (i) tyramide signal amplification (TSA) , (ii) avidin-biotinylated enzyme complexes (ABC), and (iii) branched-DNA assays (bDNA) .
- TSA tyramide signal amplification
- ABSC avidin-biotinylated enzyme complexes
- bDNA branched-DNA assays
- the capture arms of a split G-quadruplex are used to capture (or cascade) additional detection tags, detectable capture targets, or detectable molecules - for example, by binding capture nucleic acids that (i) are associated with detection tags or detectable capture tags, or (ii) are capable of binding molecules that can bind or cascade with detectable molecules.
- the capture arms of a split G-quadruplex are used to capture (or cascade) additional split G- quadruplexes , that optionally have detection tags or detectable capture tags (ex. additional capture arms capable of binding additional capture nucleic acids or split G-quadruplexes) .
- Methods of using capture tags to bind capture targets are known in the art, and are used to bind nucleic acids - associated with capture tags - to capture targets, including solid surfaces.
- Nucleic acids bound to solid surfaces are used in several methodologies, including nucleic acid precipitation, nucleic acid purification, branched DNA assays, solid phase PCR amplification, and solid phase bridge amplification (for NGS sequencing) .
- first group of capture methods - nucleic acid precipitation and nucleic acid purification - generally use a target nucleic acid associated to a capture tag, which is capable of binding a solid surface
- second group of capture methods - branched DNA, solid phase PCR, and solid phase bridge amplification - generally use a non-target nucleic acid (which is capable of hybridizing to the target nucleic acid, ex. a primer), which is associated to a capture tag, and thus capable of binding a solid surface.
- split G-quadruplexes associated to capture tags that are capable of binding both target nucleic acid (via target-binding arms) and a solid surface (via a capture tag)
- a split G-quadruplex associated to a capture tag plus a nucleic acid can substitute the target nucleic acid associated to a capture tag (in the first group) and the non-target nucleic acid associated to a capture tag plus a nucleic acid (in the second group) of the aforementioned methodologies.
- a split G-quadruplex associated to a capture tag can be used to bind a target nucleic acid to a solid surface by (i) associating a capture tag to the first strand of a split G-quadruplex,
- a split G-quadruplex associated to a capture tag can be used to bind a target nucleic acid to a solid surface by (i) associating a capture tag to the first strand of a split G-quadruplex, (ii) binding said capture tag to a solid surface, and (iii) binding the second strand of the split G-quadruplex and the target nucleic acid to the surface bound first strand of the split G-quadruplex.
- An illustration of a target nucleic acid associated to a capture tag and solid surface using said methods - is shown in Figure 1 Embodiment 4.
- a split G-quadruplex associated to a capture tag can be used to bind target nucleic acids to a solid surface, by (i) associating capture tags to the first and second strands of a split G-quadruplex, (ii) binding said first and second strands of the split G- quadruplex to a target nucleic acid, and (iii) binding said capture tag to a solid surface.
- Embodiments for binding nucleic acids to solid surfaces are useful for the first group of capture methodologies (including nucleic acid precipitation and purification) , and are useful for the second group of capture methodologies (including solid phase PCR and bridge amplification) when combined with template- directed nucleic acid synthesis - such as enzymatic methods for DNA synthesis, DNA amplification, DNA transcription, and RNA synthesis.
- template- directed nucleic acid synthesis such as enzymatic methods for DNA synthesis, DNA amplification, DNA transcription, and RNA synthesis.
- Methods of template- directed nucleic acid synthesis are known in the art, and can be classified in three groups, requiring (i) a primer (or 3' -OH terminus) for initiation, (ii) a promoter sequence for initiation, or (iii) neither primer or promoter for initiation.
- primers or promoters can be accommodated by the split G- quadruplex - with or without association to a capture tag - for example, by using the 3' -OH terminus of the second strand for initiation, or incorporating a promoter sequence (for example, flanking the target binding arm) .
- a method of template- directed nucleic acid synthesis requiring a primer is performed by (i) binding a target nucleic acid to a split G-quadruplex associated to a capture tag, and binding the capture tag to a solid surface; and (ii) initiating nucleic acid synthesis using the 3' -OH terminus of the second strand of the split G-quadruplex.
- the 3' -OH terminus of the first strand of the split G-quadruplex is modified (ex. aminated) to prevent synthesis from the first strand.
- the temperatures for target nucleic acid hybridization and enzymatic extension are below the melting temperature of the G-quadruplex.
- a method of template-directed nucleic acid synthesis requiring a promoter is performed by (i) binding a target nucleic acid to a split G-quadruplex associated to a capture tag and a promoter sequence, and binding the capture tag to a solid surface; and (ii) initiating nucleic acid synthesis using the promoter sequence associated to the split G-quadruplex.
- the promoter sequence is incorporated in a region flanking the target-binding arm.
- the promoter sequence is double-stranded nucleic acid, for example, formed by hybridizing a complementary sequence incorporated in the same or a different strand of the split G-quadruplex, or by hybridizing a complementary sequence incorporated in a nucleic acid fragment.
- Template-directed nucleic acid synthesis of the target nucleic acid can be used to strengthen the binding between the split G-quadruplex and the target nucleic acid. For example, if the nucleic acid synthesis is initiated at the 3' -OH terminus of the split G-quadruplex and is extended along the length of the target nucleic acid (downstream of the split G-quadruplex) , it creates a complementary nucleic acid that is connected to the split G-quadruplex and bound to the target nucleic acid. Depending on the length of the target nucleic acid that is downstream of the split G-quadruplex, the newly synthesized complementary fragment can be large, and can be used to strengthen the binding the split G-quadruplex and the target nucleic acid.
- the binding of a split G-quadruplex bound to a target nucleic acid is strengthen by (i) binding the split G-quadruplex to a target nucleic acid and (ii) performing template- directed nucleic acid synthesis on the target nucleic acid.
- a functional tag can be associated to a split G-quadruplex by (i) binding the split G-quadruplex to a target nucleic acid, and (ii) performing template-directed nucleic acid synthesis on the target nucleic acid utilizing nucleotides bound to functional tags.
- split G-quadruplexes for template- directed nucleic acid synthesis has two key advantages over single-stranded primers (with sequence equal to the target-binding arms) : (i) split G-quadruplexes can be designed to hybridize at much different temperatures in comparision to single stranded primers, for example by decreasing the length of one arm and increasing the length of the other arm, while maintaining the same overall sequence; and (ii) split G-quadruplexes are more specific than single-stranded primers because the individual target binding arms can be shorter than primers, and thus more sensitive to nucleotide substitutions, especially if one arm is made short in length .
- tags include amino modifications (and epoxy silane or isothiocynanate coated surfaces), thiol modifications (and mercaptosilanized surfaces), hydrazide modifications (and aldehyde or epoxide) , biotin (and immobilized streptavidin) , cholesterol-TEG (and immobilized anti-cholesterol antibodies), and digoxigenin NHS Ester (and immobilized anti-digoxigenin antibodies) .
- tags bind directly to the reactive groups on the solid surface (ex. biotin and streptavidin) , and other tags require a chemical reaction with secondary chemicals for attachment.
- micro-spheres include polystyrene micro-spheres, magnetic micro-spheres, and silica micro-spheres.
- split G-quadruplexes are advantageous for the capture of target nucleic acids, including (1) split G- quadruplexes can selectively capture a target nucleic acid based on sequence, with SNP specificity; (2) split G-quadruplexes can be readily used for template-directed nucleic acid synthesis of the target nucleic acid that has been captured, (3) split G-quadruplex can be easily denatured (ex. thermally, chemically) or digested (ex. at a engineered restriction site by a restriction enzyme) to liberate the target nucleic acid that has been captured, and (4) split G-quadruplexes can be simpler to modify than nucleic acids (ex. long synthetic nucleic acids, and especially nucleic acids isolated from biological sources) .
- the efficiency of capture can be easily monitored, for example, by (i) capturing a target nucleic acid onto a solid surface with a split G- quadruplex associated to a detection tag (or detectable capture tag) on one strand and a capture tag on the other strand ( Figure 1 Embodiment 4), (ii) removing (ex. by washing) the unbound strand with the detection tag, and (iii) monitoring the detection tag of the bound second strand by methods known in the art.
- one can (i) capture a target nucleic acid onto a solid surface with a split G-quadruplex with a detection tag on one stand (or both strands), and (ii) monitor the assembled split G-quadruplexes by monitoring its catalytic activity.
- the capture tag is associated to a strand of the G-quadrupex via a linker or spacer - for example, Phosphoramidite C3, Hexanediol, and 1 ' , 2 ' -Dideoxyribose, and preferentially Triethylene Glycol or Hexa-Ethyleneglycol .
- a linker or spacer - for example, Phosphoramidite C3, Hexanediol, and 1 ' , 2 ' -Dideoxyribose, and preferentially Triethylene Glycol or Hexa-Ethyleneglycol .
- the linker of the capture tag can be made longer.
- the linker can be made longer adding additional linker molecules to the first linker (ex.
- the linker can be made longer by adding additional nucleotides (ex. dTio, which is 10 deoxythymines ) between the capture tag and the other parts of the split G-quadruplex (ex. the target binding arm and the partial G-quadruplex sequence) .
- split G-quadruplexes and capture nucleic acids can be used together for the capture of target nucleic acids to solid surfaces.
- the split G-quadruplex has capture arms capable of binding the capture nucleic acid, and the capture nucleic acid has a capture tag capable of binding the solid surface.
- a split G- quadruplex associated to a capture tag can be used to bind a target nucleic acid to a solid surface by (i) associating a capture tag to a capture nucleic acid, (ii) binding said capture tag to a solid surface, (iii) binding the capture arm(s) of a split G-quadrupex to said capture nucleic acid, and (iv) binding a target nucleic acid to the target binding arms of said split G- quadruplex.
- a split G-quadruplex associated to a capture tag can be used to bind a target nucleic acid to a solid surface by (i) associating a capture tag to a capture nucleic acid, (ii) binding said capture tag to a solid surface, (iii) binding the target binding arms of a split G-quadruplex to a target nucleic acid, and (iv) binding the capture arms of said split G- quadruplex to said capture nucleic acid.
- An illustration of a target nucleic acid associated to a capture tag - i.e. the capture arms of a split G-quadruplex - and a solid surface using said methods, is shown in Figure 1 Embodiment 5.
- Said target nucleic acid can be detected using a second G-quadruplex associated with a detection tag (or a capture tag capable of binding detectable capture targets) - as shown in Figure 1 Embodiment 6.
- the present invention features a kit and an apparatus for using split G-quadruplexes with functional tags, for example, to detect or capture or target or crosslink target nucleic acids.
- the kit or apparatus can be point-of-care (POC) .
- POC point-of-care
- the kit or apparatus includes a split G-quadruplex associated with a functional tag.
- the kit or apparatus includes a split G-quadruplex associated with a capture tag, and a solid surface (capable of binding said capture tag) .
- the kit or apparatus includes a split G-quadruplex associated with a capture tag (capable of binding a capture nucleic acid) , a capture nucleic acid with a capture tag (capable of binding a solid surface), and a solid surface.
- a target nucleic acid with a capture tag was bound to a solid surface, washed, bound with a split G-quadruplex, washed repeatedly, and then the bound split G-quadruplex was detected.
- the utilized target nucleic acid had a capture tag and sequence 5' -/5Biosg/NN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NAA CCA TTT GGG TGT CCT GAT-3 ' (SEQ ID NO: 1) .
- the utilized split G-quadruplex specific for said target nucleic acid, comprised two oligonucleotide strands, with the first strand of sequence 5' -AT CAG GAC AC/iSp9/GGG TTG GG-3' (SEQ ID NO: 2) and the second strand of sequence 5'-GGG TAG GG/iSp9/CCA AAT GG-3' (SEQ ID NO: 3) .
- Oligonucleotides were custom-made by IDT (Coralville, Iowa) .
- Other reagents, unless otherwise indicated, were purchased from Sigma-Aldrich (St. Louis, MO) .
- Target nucleic acid 100pm was first bound to a solid surface - Pierce Streptavidin Coated High Capacity Plates (Thermo Fischer Scientific, Waltham, MA) - for 1 hour at 37 °C in Binding Buffer (50mM HEPES (pH 7.4), 20mM KC1, 50mM NaCl, 0.02% Triton X-100 (0.02% v/v) , 50mM MgCl 2 ) . The plates were washed in Wash Buffer
- a target nucleic acid with a capture tag (SEQ ID NO: 1) (100pm) was bound to a solid surface for 30 minutes at 25 ° C, washed, and then bound for 30 minutes at 25 ° C with either (i) 100pm of the first strand of a split G-quadruplex (SEQ ID NO: 2) (herein called well 1) or (ii) 100pm of the second strand of a split G-quadruplex (SEQ ID NO: 3) (herein called well 2) or (iii) both strands of a split G-quadruplex (SEQ ID NO: 2 and SEQ ID NO: 3) (herein called well 3) . Afterwards, the supernatant of well 1 (containing unbound SEQ ID NO:
- a target nucleic acid with a capture tag (SEQ ID NO: 1) was bound to a solid surface, washed, bound with a split G-quadruplex with a DIG capture tag (SEQ ID NO: 2 and sequence 5'-GGG TAG GG/iSp9/ CCA AAT GG/3DiG_N/-3' (SEQ ID NO: 5)), washed, bound for 30 minutes at 25 ° C with rabbit anti-DIG antibody (Thermo Fischer Scientific) , washed, bound for 30 minutes at 25 ° C with anti-rabbit antibody conjugated to HRP (Sigma-Aldrich) , washed, and then the catalytic activity of the HRP was triggered in Binding Buffer supplemented with lmM H 2 0 2
- split G-quadruplexes can be designed with additional target binding arms (herein called capture arms), which are capable of binding additional target nucleic acids (herein called capture nucleic acids) .
- capture arms additional target binding arms
- a split G-quadruplex with two target arms and two capture arms was designed [5' -AT CAG GAC AC /iSp9/ GGG TTG GG /iSp9/ ATT AAG TGT-3 ' (SEQ ID NO: 6) and 5'-GGC CAG TTT CAT TTG AGC / iSp9 / GGG TAG GG /iSp9/ CCA AAT GG-3' (SEQ ID NO: 7)], which was capable of binding two capture nucleic acids, that is, two strands of a second split G-quadruplex of sequence [5'- ACA CTT AAT /iSp9/ GGG TTG GG-3' (SEQ ID NO: 8) and 5'- GGG TAG GG /i
- a target nucleic acid with a capture tag (SEQ ID NO: 1) was bound to a solid surface, washed, bound with a split G-quadruplex with two target arms and two capture arms (SEQ ID NO: 6 and SEQ ID NO: 7), washed, and bound with two capture nucleic acids that were also strands of a second split G- quadruplex (SEQ ID NO: 8 and SEQ ID NO: 9), which is capable of assembling into a functional G-quadruplex (see Figure 1 Embodiment 2) .
- capture tags are capable of binding solid surfaces. These capture tags, associated to split G-quadruplexes , can be used to bind split G- quadruplexes to solid surfaces. Moreover, these split G- quadruplexes , capable of binding target nucleic acids, can be used to bind (capture) target nucleic acids to solid surfaces.
- one strand of a split G-quadruplex with a biotin capture tag [ 5' -/ 5BiosG/AT CAG GAC AC/iSp9/ GGG TTG GG-3' (SEQ ID NO: 10) ] was bound to a solid surface, washed, bound with a target nucleic acid (SEQ ID NO: 4) and the second strand of the G-quadruplex with a DIG capture tag (SEQ ID NO: 5), washed, bound with rabbit anti-DIG antibody, washed, bound with anti-rabbit antibody conjugated to HRP, washed, and then the catalytic activity of the HRP was triggered in Binding Buffer supplemented with lmM H 2 0 2 and lmM ABTS, and the 420nm absorbance of the resulting product was measured on a spectrophotometer.
- the method is similar to Figure 1 Embodiment 4,
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112020000638-6A BR112020000638A2 (en) | 2017-07-12 | 2018-07-12 | methods of associating a tag with a nucleic acid, to detect a nucleic acid and to capture a nucleic acid. |
US16/629,940 US20230193359A1 (en) | 2017-07-27 | 2018-07-12 | Split G-Quadruplexes for Capture and Detection of Nucleic Acids |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762531548P | 2017-07-12 | 2017-07-12 | |
US62/531,548 | 2017-07-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019012481A2 true WO2019012481A2 (en) | 2019-01-17 |
WO2019012481A3 WO2019012481A3 (en) | 2019-02-21 |
Family
ID=65002369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2018/055166 WO2019012481A2 (en) | 2017-07-12 | 2018-07-12 | Split g-quadruplexes for capture and detection of nucleic acids |
Country Status (2)
Country | Link |
---|---|
BR (1) | BR112020000638A2 (en) |
WO (1) | WO2019012481A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109957608A (en) * | 2019-03-05 | 2019-07-02 | 广东省生态环境技术研究所 | A kind of method and kit of label-free fluorescence detection gene |
CN112048547A (en) * | 2019-06-06 | 2020-12-08 | 同济大学 | Spinal muscular atrophy pathogenic gene detection kit and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1519725A4 (en) * | 2002-04-05 | 2005-08-10 | Cyternex Inc | METHODS OF TARGETING QUADRUPLEX DNA |
CA2740973A1 (en) * | 2007-10-23 | 2009-04-30 | Stratos Genomics Inc. | High throughput nucleic acid sequencing by spacing |
US8551768B2 (en) * | 2008-11-21 | 2013-10-08 | The Trustees Of Columbia University In The City Of New York | Split DNA enzyme for visual single nucleotide polymorphism typing |
US9175341B2 (en) * | 2008-12-11 | 2015-11-03 | Pacific Biosciences Of California, Inc. | Methods for identifying nucleic acid modifications |
US8633140B2 (en) * | 2009-02-27 | 2014-01-21 | The Regents Of The University Of Michigan | Functionalized polydiacetylene sensors |
-
2018
- 2018-07-12 BR BR112020000638-6A patent/BR112020000638A2/en unknown
- 2018-07-12 WO PCT/IB2018/055166 patent/WO2019012481A2/en active Application Filing
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109957608A (en) * | 2019-03-05 | 2019-07-02 | 广东省生态环境技术研究所 | A kind of method and kit of label-free fluorescence detection gene |
CN109957608B (en) * | 2019-03-05 | 2022-04-12 | 广东省生态环境技术研究所 | Method and kit for label-free fluorescence detection of gene |
CN112048547A (en) * | 2019-06-06 | 2020-12-08 | 同济大学 | Spinal muscular atrophy pathogenic gene detection kit and application thereof |
Also Published As
Publication number | Publication date |
---|---|
BR112020000638A2 (en) | 2020-07-14 |
WO2019012481A3 (en) | 2019-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005262357B2 (en) | Methods and compositions to detect nucleic acids in a biological sample | |
JP3907201B2 (en) | HIV probe for use in solution phase sandwich hybridization assays | |
US20100092972A1 (en) | Assay for gene expression | |
US9353404B2 (en) | Capture based nucleic acid detection | |
Kosman et al. | Bioanalytical application of peroxidase-mimicking DNAzymes: Status and challenges | |
CA2747479C (en) | Methods and reagents for shortening incubation times in hybridization assays | |
WO2019012481A2 (en) | Split g-quadruplexes for capture and detection of nucleic acids | |
JP2013524841A (en) | Method for producing a double-stranded nucleic acid having a single-stranded overhang | |
JPWO2006093097A1 (en) | Assist probe and method of using the same | |
US20230193359A1 (en) | Split G-Quadruplexes for Capture and Detection of Nucleic Acids | |
Ang et al. | Highly efficient and reliable DNA aptamer selection using the partitioning capabilities of ddPCR: the Hi-Fi SELEX method | |
US7862998B2 (en) | Assist probe and method of using the same | |
JP2006523449A (en) | Method for producing DNA fragment by selective fragmentation of nucleic acid and its application | |
EP2561098B1 (en) | Tethered enzyme mediated nucleic acid detection | |
Stocker et al. | Purification of RT‐PCR competent poly (A) mRNA from crude cell lysate by affinity precipitation | |
AU2011242404A1 (en) | Tethered enzyme mediated nucleic acid detection | |
Nanayakkara | Simplified Nucleic Acid Isolation and Detection Techniques for Point-of-Care Applications | |
JPWO2009022682A1 (en) | Target substance detection method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18831351 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112020000638 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112020000638 Country of ref document: BR Kind code of ref document: A2 Effective date: 20200110 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18831351 Country of ref document: EP Kind code of ref document: A2 |